Elanco Animal Health Inc

Organisation

450 Elanco Circle, Indianapolis, IN, United States, 46221

Headquarters

9400

Employees

Process Industries

Industry

Jeff Simmons

Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide. The company offers pet health products, such as parasiticides, vaccines, and therapeutics that protect pets from fleas, ticks, and internal parasites under the Seresto, K-9 Advantage, Advantix, and Advocate trademarks; prescription parasiticide products, an over-the-counter treatments for the prevention and elimination of fleas and ticks under the Credelio Family, Interceptor Plus, Drontal family, and Drontal Plus; vaccines portfolio that provides differentiated prevention coverage for a number of important pet health risks; and therapeutics portfolio for the treatment of pain, otitis, cardiovascular, and dermatology indications, as well as osteoarthritis for dogs and cats under the Galliprant trademark. It also provides farm animal products that help farmers improve animal health and wellbeing, and raise livestock, such as cattle, swine, and poultry. In addition, the company offers medicated feed additives, injectable antibiotics, vaccines, insecticides and enzymes, and others under the Rumensin, Baytril, and Experior trademarks for cattle; and under the Maxiban and Monteban trademarks for the control and prevention of intestinal disease in poultry. Further, it offers other pet health products for cats and dogs under the Atopica, Milbemax, Onsior, and Tru Family trademarks; and other farm animal products for poultry, cattle, and swine under the AviPro, Catosal, Denagard, Hemicell, Pulmotil, and Surmax tradmarks. The company sells its products to third-party distributors and independent retailers; and directly to farm animal producers and veterinarians. Elanco Animal Health Incorporated was founded in 1954 and is headquartered in Indianapolis, Indiana.

Price

Target

Elanco Animal Health Inc (ELAN) Price vs Consensus Price Target

As per the chart shown above, analysts believe that the Elanco Animal Health Inc (ELAN) share price will touch around $28.77 in next 12-months.

Currently 21 wall-street analysts regularly analyze the financials of Elanco Animal Health Inc on a frequent basis to provide recommendations along with target share price. 21 analysts offering 12-month price forecasts for Elanco Animal Health Inc (ELAN) have a share price target of $28.77. This median of share price forecast represents a 19.97% upside from the latest price of $23.98 as on 23.03.26.

Elanco Animal Health Inc (ELAN) Share Price Forecast

Home

US Stocks

Elanco Animal Health Inc (ELAN)

Elanco Animal Health Inc Stock Forecast

Elanco Animal Health Inc Stock Forecast & Price Target (Analyst Recommendation) | INDmoney

Percentage Difference

Elanco Animal Health Inc (ELAN): Difference between Current Price & Median Forecasted Price

Below is a chart showing the percentage difference between Elanco Animal Health Inc's share price and its median forecast price. As on 23.03.26, the difference is -9.52%

Elanco Animal Health Inc Forecast and Target Price

Elanco Animal Health Inc (ELAN) Share Price Forecast

Elanco Animal Health Inc (ELAN) Price vs Consensus Price Target

Elanco Animal Health Inc (ELAN) Share Price Forecast v/s Share Price Today

Elanco Animal Health Inc (ELAN): Difference between Current Price & Median Forecasted Price

Elanco Animal Health Inc (ELAN) Share Price Technical Analysis

50 Day Moving Average v/s Current Share Price

200 Day Moving Average v/s Current Share Price